{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T15:33:14Z","timestamp":1772638394131,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T00:00:00Z","timestamp":1557187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_12015\/4"],"award-info":[{"award-number":["MC_UU_12015\/4"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["08\/116\/300"],"award-info":[{"award-number":["08\/116\/300"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["G061895"],"award-info":[{"award-number":["G061895"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007602","name":"Programme Grants for Applied Research","doi-asserted-by":"publisher","award":["RP-PG-0606-1259"],"award-info":[{"award-number":["RP-PG-0606-1259"]}],"id":[{"id":"10.13039\/501100007602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00125-019-4886-1","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T16:18:59Z","timestamp":1557245939000},"page":"1391-1402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Moderate weight change following diabetes diagnosis and 10\u00a0year incidence of cardiovascular disease and mortality"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4051-6944","authenticated-orcid":false,"given":"Jean","family":"Strelitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy L.","family":"Ahern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gr\u00e1inne H.","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J. L.","family":"Hare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Irving","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare E.","family":"Boothby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Wareham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon J.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,7]]},"reference":[{"issue":"1","key":"4886_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"TR Einarson","year":"2018","unstructured":"Einarson TR, Acs A, Ludwig C, Panton UH (2018) Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovasc Diabetol 17(1):83. \n                    https:\/\/doi.org\/10.1186\/s12933-018-0728-6","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"4886_CR2","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.jval.2017.12.019","volume":"21","author":"TR Einarson","year":"2018","unstructured":"Einarson TR, Acs A, Ludwig C, Panton UH (2018) Economic burden of cardiovascular disease in type 2 diabetes: a systematic review. Value Health 21(7):881\u2013890. \n                    https:\/\/doi.org\/10.1016\/j.jval.2017.12.019","journal-title":"Value Health"},{"key":"4886_CR3","unstructured":"Diabetes UK (2014) The cost of diabetes: report. Available form \n                    www.diabetes.org.uk\/resources-s3\/2017-11\/diabetes%20uk%20cost%20of%20diabetes%20report.pdf\n                    \n                  . Accessed 1 October 2018"},{"issue":"17","key":"4886_CR4","first-page":"1566","volume":"170","author":"Look AHEAD Research Group","year":"2010","unstructured":"Look AHEAD Research Group (2010) Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 170(17):1566\u20131575","journal-title":"Arch Intern Med"},{"issue":"9","key":"4886_CR5","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.jand.2015.02.031","volume":"115","author":"MJ Franz","year":"2015","unstructured":"Franz MJ, Boucher JL, Rutten-Ramos S, VanWormer JJ (2015) Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. J Acad Nutr Diet 115(9):1447\u20131463. \n                    https:\/\/doi.org\/10.1016\/j.jand.2015.02.031","journal-title":"J Acad Nutr Diet"},{"issue":"2","key":"4886_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJMoa1212914","volume":"369","author":"The Look AHEAD Research Group","year":"2013","unstructured":"The Look AHEAD Research Group (2013) Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 369(2):145\u2013154. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1212914","journal-title":"N Engl J Med"},{"issue":"10120","key":"4886_CR7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","volume":"391","author":"ME Lean","year":"2018","unstructured":"Lean ME, Leslie WS, Barnes AC et al (2018) Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 391(10120):541\u2013551. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(17)33102-1","journal-title":"Lancet"},{"issue":"7","key":"4886_CR8","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2337\/dc10-2415","volume":"34","author":"RR Wing","year":"2011","unstructured":"Wing RR, Lang W, Wadden TA et al (2011) Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 34(7):1481\u20131486. \n                    https:\/\/doi.org\/10.2337\/dc10-2415","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"4886_CR9","first-page":"14","volume":"106","author":"DF Williamson","year":"1998","unstructured":"Williamson DF (1998) Weight loss and mortality in persons with type-2 diabetes mellitus: a review of the epidemiological evidence. Exp Clin Endocrinol Diabetes 106(Suppl 2):14\u201321","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"11","key":"4886_CR10","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S2213-8587(16)30162-0","volume":"4","author":"EW Gregg","year":"2016","unstructured":"Gregg EW, Jakicic JM, Blackburn G et al (2016) Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol 4(11):913\u2013921","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"4886_CR11","doi-asserted-by":"publisher","first-page":"e010836","DOI":"10.1136\/bmjopen-2015-010836","volume":"6","author":"LS Aucott","year":"2016","unstructured":"Aucott LS, Philip S, Avenell A, Afolabi E, Sattar N, Wild S (2016) Patterns of weight change after the diagnosis of type 2 diabetes in Scotland and their relationship with glycaemic control, mortality and cardiovascular outcomes: a retrospective cohort study. BMJ Open 6(7):e010836. \n                    https:\/\/doi.org\/10.1136\/bmjopen-2015-010836","journal-title":"BMJ Open"},{"issue":"4","key":"4886_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.diabet.2013.05.004","volume":"39","author":"J Bodegard","year":"2013","unstructured":"Bodegard J, Sundstrom J, Svennblad B, Ostgren CJ, Nilsson PM, Johansson G (2013) Changes in body mass index following newly diagnosed type 2 diabetes and risk of cardiovascular mortality: a cohort study of 8486 primary-care patients. Diabetes Metab 39(4):306\u2013313. \n                    https:\/\/doi.org\/10.1016\/j.diabet.2013.05.004","journal-title":"Diabetes Metab"},{"issue":"3","key":"4886_CR13","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.ypmed.2004.02.026","volume":"39","author":"AA Gorin","year":"2004","unstructured":"Gorin AA, Phelan S, Hill JO, Wing RR (2004) Medical triggers are associated with better short- and long-term weight loss outcomes. Prev Med 39(3):612\u2013616. \n                    https:\/\/doi.org\/10.1016\/j.ypmed.2004.02.026","journal-title":"Prev Med"},{"issue":"24","key":"4886_CR14","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","volume":"358","author":"A Patel","year":"2008","unstructured":"Patel A, MacMahon S, Chalmers J et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358(24):2560\u20132572","journal-title":"N Engl J Med"},{"issue":"9739","key":"4886_CR15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","volume":"376","author":"F Ismail-Beigi","year":"2010","unstructured":"Ismail-Beigi F, Craven T, Banerji MA et al (2010) Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 376(9739):419\u2013430. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(10)60576-4","journal-title":"Lancet"},{"issue":"15","key":"4886_CR16","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359(15):1577\u20131589. \n                    https:\/\/doi.org\/10.1056\/NEJMoa0806470","journal-title":"N Engl J Med"},{"issue":"1","key":"4886_CR17","doi-asserted-by":"publisher","first-page":"e0146889","DOI":"10.1371\/journal.pone.0146889","volume":"11","author":"R Koster-Rasmussen","year":"2016","unstructured":"Koster-Rasmussen R, Simonsen MK, Siersma V, Henriksen JE, Heitmann BL, de Fine Olivarius N (2016) Intentional weight loss and longevity in overweight patients with type 2 diabetes: a population-based cohort study. PLoS One 11(1):e0146889. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0146889","journal-title":"PLoS One"},{"issue":"29","key":"4886_CR18","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S et al (2016) 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts): developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 37(29):2315\u20132381","journal-title":"Eur Heart J"},{"issue":"1","key":"4886_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1471-2458-9-136","volume":"9","author":"JB Echouffo-Tcheugui","year":"2009","unstructured":"Echouffo-Tcheugui JB, Simmons RK, Williams KM et al (2009) The ADDITION\u2013Cambridge trial protocol: a cluster\u2014randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients. BMC Public Health 9(1):136. \n                    https:\/\/doi.org\/10.1186\/1471-2458-9-136","journal-title":"BMC Public Health"},{"issue":"3","key":"4886_CR20","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/1520-7560(200005\/06)16:3<164::AID-DMRR103>3.0.CO;2-R","volume":"16","author":"SJ Griffin","year":"2000","unstructured":"Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ (2000) Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 16(3):164\u2013171. \n                    https:\/\/doi.org\/10.1002\/1520-7560(200005\/06)16:3<164::AID-DMRR103>3.0.CO;2-R","journal-title":"Diabetes Metab Res Rev"},{"issue":"9","key":"4886_CR21","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/j.1464-5491.2010.03056.x","volume":"27","author":"LA Sargeant","year":"2010","unstructured":"Sargeant LA, Simmons RK, Barling RS et al (2010) Who attends a UK diabetes screening programme? Findings from the ADDITION\u2013Cambridge study. Diabet Med 27(9):995\u20131003. \n                    https:\/\/doi.org\/10.1111\/j.1464-5491.2010.03056.x","journal-title":"Diabet Med"},{"key":"4886_CR22","unstructured":"World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: WHO, 1999. Available from \n                    https:\/\/apps.who.int\/iris\/handle\/10665\/66040\n                    \n                  . Accessed 1 October 2018"},{"key":"4886_CR23","unstructured":"McIntosh A, Hutchinson A, Home P et al Clinical guidelines and evidence review for type 2 diabetes: blood glucose management. Sheffield: ScHARR, University of Sheffield. 2001. Available from \n                    https:\/\/www.nice.org.uk\/guidance\/g\/documents\/type-2-diabetes-glycaemic-control2\n                    \n                  . Accessed 1 November 2018"},{"key":"4886_CR24","unstructured":"Hutchinson A, McIntosh A, Griffiths C et al Clinical guidelines and evidence review for type 2 diabetes: management of blood pressure. Sheffield: ScHARR, University of Sheffield. 2002. Available from \n                    https:\/\/www.nice.org.uk\/guidance\/ng28\/chapter\/1-recommendations#blood-pressure-management-2\n                    \n                   . Accessed 1 November 2018"},{"key":"4886_CR25","unstructured":"McIntosh A, Hutchinson A, Feder G et al Clinical guidelines and evidence review for type 2 diabetes: lipids management. Sheffield: ScHARR, University of Sheffield. 2002. Available from \n                    https:\/\/www.academia.edu\/2978743\/Clinical_guidelines_and_evidence_review_for_type_2_diabetes_lipids_management\n                    \n                  . Accessed 1 November 2018"},{"key":"4886_CR26","volume-title":"CASOC: computer-assisted standard occupational coding","author":"P Elias","year":"1993","unstructured":"Elias P, Halstead K, Prandy K (1993) CASOC: computer-assisted standard occupational coding. HMSO, London"},{"issue":"16","key":"4886_CR27","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1136\/hrt.2009.192328","volume":"96","author":"E Herrett","year":"2010","unstructured":"Herrett E, Smeeth L, Walker L, Weston C, Group MA (2010) The Myocardial Ischaemia National Audit Project (MINAP). Heart 96(16):1264\u20131267. \n                    https:\/\/doi.org\/10.1136\/hrt.2009.192328","journal-title":"Heart"},{"issue":"Suppl 2","key":"4886_CR28","doi-asserted-by":"publisher","first-page":"211s","DOI":"10.1002\/j.1550-8528.1995.tb00466.x","volume":"3","author":"G Blackburn","year":"1995","unstructured":"Blackburn G (1995) Effect of degree of weight loss on health benefits. Obes Res 3(Suppl 2):211s\u2013216s. \n                    https:\/\/doi.org\/10.1002\/j.1550-8528.1995.tb00466.x","journal-title":"Obes Res"},{"issue":"Suppl 2","key":"4886_CR29","first-page":"51S","volume":"6","author":"National Institutes of Health","year":"1998","unstructured":"National Institutes of Health (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults\u2014the evidence report. National Institutes of Health. Obes Res 6(Suppl 2):51S\u2013209S","journal-title":"Obes Res"},{"issue":"1","key":"4886_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00001648-199901000-00008","volume":"10","author":"S Greenland","year":"1999","unstructured":"Greenland S, Pearl J, Robins JM (1999) Causal diagrams for epidemiologic research. Epidemiology 10(1):37\u201348. \n                    https:\/\/doi.org\/10.1097\/00001648-199901000-00008","journal-title":"Epidemiology"},{"issue":"2","key":"4886_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1532-5415.2010.03245.x","volume":"59","author":"CG Lee","year":"2011","unstructured":"Lee CG, Boyko EJ, Nielson CM et al (2011) Mortality risk in older men associated with changes in weight, lean mass, and fat mass. J Am Geriatr Soc 59(2):233\u2013240. \n                    https:\/\/doi.org\/10.1111\/j.1532-5415.2010.03245.x","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"4886_CR32","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1046\/j.1532-5415.2002.50509.x","volume":"50","author":"NM Wedick","year":"2002","unstructured":"Wedick NM, Barrett-Connor E, Knoke JD, Wingard DL (2002) The relationship between weight loss and all-cause mortality in older men and women with and without diabetes mellitus: the Rancho Bernardo study. J Am Geriatr Soc 50(11):1810\u20131815. \n                    https:\/\/doi.org\/10.1046\/j.1532-5415.2002.50509.x","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"4886_CR33","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1111\/jgs.12954","volume":"62","author":"RA Murphy","year":"2014","unstructured":"Murphy RA, Patel KV, Kritchevsky SB et al (2014) Weight change, body composition, and risk of mobility disability and mortality in older adults: a population-based cohort study. J Am Geriatr Soc 62(8):1476\u20131483. \n                    https:\/\/doi.org\/10.1111\/jgs.12954","journal-title":"J Am Geriatr Soc"},{"issue":"28","key":"4886_CR34","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1002\/sim.3944","volume":"29","author":"IR White","year":"2010","unstructured":"White IR, Carlin JB (2010) Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values. Stat Med 29(28):2920\u20132931. \n                    https:\/\/doi.org\/10.1002\/sim.3944","journal-title":"Stat Med"},{"issue":"446","key":"4886_CR35","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94(446):496\u2013509. \n                    https:\/\/doi.org\/10.1080\/01621459.1999.10474144","journal-title":"J Am Stat Assoc"},{"issue":"11","key":"4886_CR36","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(15)00334-4","volume":"3","author":"B Eliasson","year":"2015","unstructured":"Eliasson B, Liakopoulos V, Franzen S et al (2015) Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study. Lancet Diabetes Endocrinol 3(11):847\u2013854. \n                    https:\/\/doi.org\/10.1016\/S2213-8587(15)00334-4","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"4886_CR37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s13679-017-0262-y","volume":"6","author":"DH Ryan","year":"2017","unstructured":"Ryan DH, Yockey SR (2017) Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over. Curr Obes Rep 6(2):187\u2013194. \n                    https:\/\/doi.org\/10.1007\/s13679-017-0262-y","journal-title":"Curr Obes Rep"},{"issue":"5223","key":"4886_CR38","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1136\/bmj.1.5223.379","volume":"1","author":"B Bronte-Stewart","year":"1961","unstructured":"Bronte-Stewart B (1961) Cigarette smoking and ischaemic heart disease. Br Med J 1(5223):379\u2013384. \n                    https:\/\/doi.org\/10.1136\/bmj.1.5223.379","journal-title":"Br Med J"},{"issue":"19","key":"4886_CR39","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1161\/CIRCULATIONAHA.107.729939","volume":"116","author":"S Mora","year":"2007","unstructured":"Mora S, Cook N, Buring JE, Ridker PM, Lee IM (2007) Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation. 116(19):2110\u20132118. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.729939","journal-title":"Circulation."},{"issue":"10","key":"4886_CR40","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S2213-8587(14)70034-8","volume":"2","author":"RR Kalyani","year":"2014","unstructured":"Kalyani RR, Corriere M, Ferrucci L (2014) Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol 2(10):819\u2013829. \n                    https:\/\/doi.org\/10.1016\/S2213-8587(14)70034-8","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"34","key":"4886_CR41","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1093\/eurheartj\/ehv239","volume":"36","author":"E Ferrannini","year":"2015","unstructured":"Ferrannini E, DeFronzo RA (2015) Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes. Eur Heart J 36(34):2288\u20132296. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehv239","journal-title":"Eur Heart J"},{"issue":"3","key":"4886_CR42","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1463-1326.2009.01155.x","volume":"12","author":"K Fujioka","year":"2010","unstructured":"Fujioka K (2010) Benefits of moderate weight loss in patients with type 2 diabetes. Diabetes Obes Metab 12(3):186\u2013194. \n                    https:\/\/doi.org\/10.1111\/j.1463-1326.2009.01155.x","journal-title":"Diabetes Obes Metab"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-019-4886-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-019-4886-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-019-4886-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T23:20:10Z","timestamp":1588720810000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-019-4886-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,7]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["4886"],"URL":"https:\/\/doi.org\/10.1007\/s00125-019-4886-1","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,7]]},"assertion":[{"value":"11 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SJG reports grants from the Wellcome Trust, MRC, NIHR, NIHR Health Technology Assessment Programme, NHS R&D and the University of Aarhus (Denmark), and provision of equipment from Bio-Rad during the conduct of the study. Outside the submitted work he also reports receiving fees from Novo Nordisk, AstraZeneca and Napp for speaking at postgraduate education meetings, support to attend a scientific meeting from Napp, and an honorarium and reimbursement of travel expenses from Eli Lilly associated with membership of an independent data monitoring committee for a randomised trial of a medication to lower glucose. ALA is principal investigator on two trials where research costs are funded by national research councils (NIHR and the National Prevention Research Initiative) and where the intervention is provided at no cost by Weight Watchers International. The other authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}}]}}